Neuromuscular Disorders - Clinical Trials | Hospital for Special Care
Source: https://hfsc.org/about/clinical-trials
Archived: 2026-04-23 17:32
Neuromuscular Disorders - Clinical Trials | Hospital for Special Care
860-223-2761
Make a Donation
Aquatic & Fitness Center
Patient Login
Pay My Bill
Skip to content
Home
>
About
>
Clinical Trials
It is our mission to enhance the practice of rehabilitation and continuing medical care through research and education. This is why we are active in conducting clinical trials and evaluating new treatments, technologies, and finding new solutions. We are uniquely skilled to conduct clinical trials in the areas of, neuromuscular care including Amyotrophic Lateral Sclerosis (ALS) and Muscular Dystrophy, as well as Parkinson’s Disease. As a participant in one of our clinical trials, you have the opportunity to enhance your care and ensure that future generations have access to the highest level of care.
Six Active Research Projects
HEALEY ALS PLATFORM
– A Platform Trial in which multiple interventions are tested and evaluated simultaneously for the Treatment of ALS. Placebo / Control Phase – 25% receive placebo vs 75% receive active drug, then followed by active treatment.
ALL ALS East Biorepository – A large biomarker study that follows 3 groups of patients:
Assess (2 groups): Patients with ALS and patients without ALS (controls)
Prevent: Family members of patients with known genetic cause of ALS
Pridopidine
Expanded Access Protocol (
EAP) 2 – Oral Pridopidine treatment for patients diagnosed with ALS that do not qualify for other clinical trials.
Clene Nanomedicine CNM-Au8
– A Second Intermediate Expanded Access Protocol (EAP) for ALS with CNM-Au8
Ibudilast EAP – A compassionate use EAP of MN-166 for patients with ALS
Usnoflast-Phase 2b – ALS patients treated with oral USNO.24.002
About
Accreditations
Clinical Trials
Leadership
Locations
Our History
Have questions about our clinical trials and research? Please call
860-612-6356
We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. For more information about these cookies and the data collected, please refer to our website
privacy policy
.
860-223-2761
Make a Donation
Aquatic & Fitness Center
Patient Login
Pay My Bill
Skip to content
Home
>
About
>
Clinical Trials
It is our mission to enhance the practice of rehabilitation and continuing medical care through research and education. This is why we are active in conducting clinical trials and evaluating new treatments, technologies, and finding new solutions. We are uniquely skilled to conduct clinical trials in the areas of, neuromuscular care including Amyotrophic Lateral Sclerosis (ALS) and Muscular Dystrophy, as well as Parkinson’s Disease. As a participant in one of our clinical trials, you have the opportunity to enhance your care and ensure that future generations have access to the highest level of care.
Six Active Research Projects
HEALEY ALS PLATFORM
– A Platform Trial in which multiple interventions are tested and evaluated simultaneously for the Treatment of ALS. Placebo / Control Phase – 25% receive placebo vs 75% receive active drug, then followed by active treatment.
ALL ALS East Biorepository – A large biomarker study that follows 3 groups of patients:
Assess (2 groups): Patients with ALS and patients without ALS (controls)
Prevent: Family members of patients with known genetic cause of ALS
Pridopidine
Expanded Access Protocol (
EAP) 2 – Oral Pridopidine treatment for patients diagnosed with ALS that do not qualify for other clinical trials.
Clene Nanomedicine CNM-Au8
– A Second Intermediate Expanded Access Protocol (EAP) for ALS with CNM-Au8
Ibudilast EAP – A compassionate use EAP of MN-166 for patients with ALS
Usnoflast-Phase 2b – ALS patients treated with oral USNO.24.002
About
Accreditations
Clinical Trials
Leadership
Locations
Our History
Have questions about our clinical trials and research? Please call
860-612-6356
We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. For more information about these cookies and the data collected, please refer to our website
privacy policy
.